Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Delamanid by Otsuka Pharmaceutical for Pulmonary Tuberculosis: Likelihood of Approval
Delamanid is under clinical development by Otsuka Pharmaceutical and currently in Phase III for Pulmonary Tuberculosis. According to GlobalData, Phase...